Objectives: Advances in science and technology have meant there are numerous treatment options available for people with advanced breast cancer (ABC). However, each therapeutic approach can cause side effects or adverse events, which can significantly affect the person's quality of life, overall well-being, and, in some instances, safety. This report presents an overview of the common side effects of systemic anticancer therapy and ways to manage them. Data Sources: Data sources include peer-reviewed articles sourced in electronic databases and national and international best practice guidelines (ESMO, ASCO, and MASCC guidelines). Conclusion: Systemic anticancer therapies have side effects that healthcare professionals need to k...
The present final consensus statement of the French Society of Endocrinology lays out the assessment...
One of the characteristics that distinguish anticancer agents from other drugs is the frequency and ...
The appropriate selection of medical therapeutic interventions in breast cancer patients is a daily ...
Introduction and purpose Breast cancer (BC) management includes local therapies surgery, radiotherap...
Background: This study explores the incidence of patient-reported major toxicity—symptoms rated “mod...
In the world the cancer is a prevailing disease therefore some rational and effective therapy requir...
As more women are surviving breast cancer the focus is shifting on the side effects that may hinder ...
Background: The National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminol...
BACKGROUND:New chemotherapic agents and new protocols in oncology have led to an increasing survival...
Breast cancer is still a lethal disease and the leading cause of death in women, undermining patient...
Systemic treatment for breast cancer is given as neoadjuvent therapy to reduce tumour bulk before su...
Rapid advances in cancer immunotherapy using Immune Checkpoint Inhibitors have led to significantly ...
Antiblastic drugs have a high number of potential side-effects. Paradoxically, according to the Nati...
Background: Breast cancer is the most common type of cancer in women worldwide. The benefits of chem...
Patients with breast cancer receiving chemotherapy are at risk of developing toxicities which can be...
The present final consensus statement of the French Society of Endocrinology lays out the assessment...
One of the characteristics that distinguish anticancer agents from other drugs is the frequency and ...
The appropriate selection of medical therapeutic interventions in breast cancer patients is a daily ...
Introduction and purpose Breast cancer (BC) management includes local therapies surgery, radiotherap...
Background: This study explores the incidence of patient-reported major toxicity—symptoms rated “mod...
In the world the cancer is a prevailing disease therefore some rational and effective therapy requir...
As more women are surviving breast cancer the focus is shifting on the side effects that may hinder ...
Background: The National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminol...
BACKGROUND:New chemotherapic agents and new protocols in oncology have led to an increasing survival...
Breast cancer is still a lethal disease and the leading cause of death in women, undermining patient...
Systemic treatment for breast cancer is given as neoadjuvent therapy to reduce tumour bulk before su...
Rapid advances in cancer immunotherapy using Immune Checkpoint Inhibitors have led to significantly ...
Antiblastic drugs have a high number of potential side-effects. Paradoxically, according to the Nati...
Background: Breast cancer is the most common type of cancer in women worldwide. The benefits of chem...
Patients with breast cancer receiving chemotherapy are at risk of developing toxicities which can be...
The present final consensus statement of the French Society of Endocrinology lays out the assessment...
One of the characteristics that distinguish anticancer agents from other drugs is the frequency and ...
The appropriate selection of medical therapeutic interventions in breast cancer patients is a daily ...